20 research outputs found

    Energy Scenarios for South Eastern Europe: A close look into the Western Balkans

    Get PDF
    "The Energy Scenarios for South East Europe" thematic seminar took place on the 15th of December 2015 in Vienna, Austria. The workshop was organized by Institute of Energy and Transport of the European Commission's Joint Research Centre (JRC-IET), hosted by the Energy Community Secretariat (ECS) and sponsored by the Directorate-General for Neighbourhood and Enlargement Negotiations (DG-NEAR) in the framework of the Travel Accommodation and Conference facility for Western Balkans and Turkey, a programme of dissemination activities organised by the Commission in the EU or the beneficiary country in connection with the enlargement process and the pre-accession strategy. The aim of the workshop was to bring together representatives from think tanks, scientific institutes, the academia and the private sector with government officials, the national statistical agencies and the local TSO representatives from the Western Balkan region to exchange views on potential energy technology deployment scenarios that could facilitate a low carbon development pathway for the enlargement countries, but also exchange on the methodologies utilized and identify challenges as well as potential pitfalls in this process. The workshop included three sessions of specific thematic focus. The first session provided the "regional picture" with forecasts on the development of the energy and power systems in the western Balkans. The second session discussed case studies on low carbon development trajectories for specific countries in the region; and the third session explored the role of particular technologies in this context. This report comprises of long abstracts from the workshop presentations and closes with a chapter on conclusions and recommendations that resulted from the discussion sessions

    Cell-type dependent response of melanoma cells to aloe emodin

    Full text link
    Intrinsic characteristics of melanoma cells such as expression of inducible nitric oxide synthase (iNOS), redox status, and activity of signaling pathways involved in proliferation, differentiation and cell death define the response of the cells to the diverse treatments. In this context we compared the effectiveness of herbal antaquinone aloe emodin (AE) against mouse B16 melanoma and human A375, different in initial activity of ERK1/2, constitutive iNOS expression and basal level of reactive oxygen species (ROS). Both cell lines are sensitive to AE treatment. However, while the agent induces differentiation of B16 cells toward melanocytes, in A375 cells promoted massive apoptosis. Differentiation of B16 cells, characterized by enhanced melanin production and tyrosinase activity, was mediated by H2O2 production synchronized with rapid p53 accumulation and enhanced expression of cyclins D1 and D3. Caspase mediated apoptosis triggered in A375 cells was accompanied with Bcl-2 but not iNOS down-regulation. In addition, opposite regulation of Akt-ERK1/2 axis in AE treated B16 and A375 cells correlated with different outcome of the treatment. However, AE in a dose-dependent manner rescued both B16 and A375 cells from doxorubicin- or paclitaxel-induced killing. These data indicate that caution is warranted when AE is administrated to the patients with conventional chemotherapy

    Cell-type dependent response of melanoma cells to aloe emodin

    Full text link
    Intrinsic characteristics of melanoma cells such as expression of inducible nitric oxide synthase (iNOS), redox status, and activity of signaling pathways involved in proliferation, differentiation and cell death define the response of the cells to the diverse treatments. In this context we compared the effectiveness of herbal antaquinone aloe emodin (AE) against mouse B16 melanoma and human A375, different in initial activity of ERK1/2, constitutive iNOS expression and basal level of reactive oxygen species (ROS). Both cell lines are sensitive to AE treatment. However, while the agent induces differentiation of B16 cells toward melanocytes, in A375 cells promoted massive apoptosis. Differentiation of B16 cells, characterized by enhanced melanin production and tyrosinase activity, was mediated by H2O2 production synchronized with rapid p53 accumulation and enhanced expression of cyclins D1 and D3. Caspase mediated apoptosis triggered in A375 cells was accompanied with Bcl-2 but not iNOS down-regulation. In addition, opposite regulation of Akt-ERK1/2 axis in AE treated B16 and A375 cells correlated with different outcome of the treatment. However, AE in a dose-dependent manner rescued both B16 and A375 cells from doxorubicin- or paclitaxel-induced killing. These data indicate that caution is warranted when AE is administrated to the patients with conventional chemotherapy. (C) 2012 Elsevier Ltd. All rights reserved.Ministry of Education and Science of the Republic of Serbia [173013

    Cell-type dependent response of melanoma cells to aloe emodin

    Full text link
    Intrinsic characteristics of melanoma cells such as expression of inducible nitric oxide synthase (iNOS), redox status, and activity of signaling pathways involved in proliferation, differentiation and cell death define the response of the cells to the diverse treatments. In this context we compared the effectiveness of herbal antaquinone aloe emodin (AE) against mouse B16 melanoma and human A375, different in initial activity of ERK1/2, constitutive iNOS expression and basal level of reactive oxygen species (ROS). Both cell lines are sensitive to AE treatment. However, while the agent induces differentiation of B16 cells toward melanocytes, in A375 cells promoted massive apoptosis. Differentiation of B16 cells, characterized by enhanced melanin production and tyrosinase activity, was mediated by H2O2 production synchronized with rapid p53 accumulation and enhanced expression of cyclins D1 and D3. Caspase mediated apoptosis triggered in A375 cells was accompanied with Bcl-2 but not iNOS down-regulation. In addition, opposite regulation of Akt-ERK1/2 axis in AE treated B16 and A375 cells correlated with different outcome of the treatment. However, AE in a dose-dependent manner rescued both B16 and A375 cells from doxorubicin- or paclitaxel-induced killing. These data indicate that caution is warranted when AE is administrated to the patients with conventional chemotherapy. (C) 2012 Elsevier Ltd. All rights reserved.Ministry of Education and Science of the Republic of Serbia [173013
    corecore